OptimizeRx Corporation (OPRX) Investor Relations Documents

OptimizeRx Corporation (OPRX) investor relations documents from the company's IR site: 40 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-12Press releasePress release
2026-08-12Press releaseOptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
2026-08-12Press releaseOptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
2026-07-29Press releasePress release
2026-07-29Press releaseOptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
2026-07-23Press releasePress release
2026-07-23Press releaseOptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
2026-06-30Press releasePress release
2026-06-30Press releaseOptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
2026-06-25Press releasePress release
2026-06-25Press releaseOptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
2026-06-06Press releasePress release
2026-06-01Press releasePress release
2026-06-01Press releaseOptimizeRx to Participate in Upcoming Investor Conferences
2026-05-21Press releaseDeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
2026-05-12Press releasePress release
2026-05-12Press releaseOptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
2026-05-11Press releasePress release
2026-05-11Press releaseOptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
2026-04-29Press releasePress release
2026-04-28Press releasePress release
2026-04-28Press releaseOptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
2026-04-08Press releasePress release
2026-04-08Press releaseOptimizeRx Appoints Mary Varghese Presti to Board of Directors
Press releaseOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
2026-03-05Press releasePress release
2026-03-05Press releasePress release
2026-03-05Press releaseUPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
2026-02-05Press releasePress release
2026-02-05Press releaseOptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
2026-01-07Press releasePress release
2026-01-07Press releaseOptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
2025-12-17Press releasePress release
Press releaseOptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
2025-11-06Press releasePress release
Press releaseOptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
2025-10-20Press releasePress release
2025-09-10Press releasePress release
2025-09-09Press releasePress release
2025-08-19Press releasePress release

OPRX overview · OPRX earnings · OPRX financials · OPRX KPIs · OPRX ownership · OPRX peers · OPRX filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.